Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSherborne Inv C Regulatory News (SIGC)

Share Price Information for Sherborne Inv C (SIGC)

Share Price is delayed by 15 minutes
Get Live Data
32.20    0.00 (0.00%)
Bid:
31.40
Ask:
33.00
Spread: 1.60 (5.096%)
Market Cap: £208.46m
SIGC Live PriceLast checked at - London Stock Exchange

Intraday Sherborne Inv C Share Chart

Directorate Change

16 Jan 2023 07:00

RNS Number : 7306M
Sherborne Investors (Guernsey)C Ltd
16 January 2023
 

16 January 2023

 

SHERBORNE INVESTORS (GUERNSEY) C LIMITED

Director Changes

 

The board of Sherborne Investors (Guernsey) C Limited (the "Company") is pleased to announce the appointments of Helen Sinclair and Linda Wilding to the Board as non-executive Directors with effect from 1 February 2023.

 

Helen Sinclair is a highly experienced non-executive director, having served on various audit, remuneration, risk and investment committees. Prior to her focus on these roles, she co-founded and ran Matrix Private Equity (now Mobeus Equity Partners LLP), a successful private equity house. She is an Economics graduate of Cambridge University.

 

Linda Wilding is an experienced Chair and non-executive director in both the public and private equity arenas. She has experience in various sectors including consumer products, leisure, medical devices, pharma services, property, investment and financial services. She is a Chartered Accountant and holds a PhD in Biochemistry.

 

Talmai Morgan, Chair of the Company, commented:

 

"I am absolutely delighted to welcome two such extremely well qualified and experienced individuals to the Board. I look forward to working with them for the benefit of the Company and its shareholders. Chris Legge will be retiring at the Company's 2023 AGM and Linda Wilding will take over as Chair of the Audit Committee. I would like to take this opportunity to thank Chris for the valuable contribution which he has made to the Company and for having been such a wonderful colleague."

 

Pursuant to Listing Rule 9.6.13 the following disclosures are made:

 

Helen Sinclair is a non-executive director of Blackrock Smaller Companies Trust plc, Octopus Future Generations VCT plc, Shires Income plc and W H Ireland Group plc.

 

Linda Wilding is a non-executive director of Balanced Commercial Property Trust Ltd. Further, she is formerly a non-executive director of UDG Healthcare plc and Electra Private Equity plc.

 

For further information:

 

Dentons Global Advisors +44 (0)20 7664 5095

Jonathon Brill

James Styles

 

Numis Securities Limited (Broker) +44 (0)20 7260 1000

David Benda

Nathan Brown

 

Sherborne Investors (Guernsey) C Limited +44 (0)20 3530 3600

Talmai Morgan (Chair)

Matt Lihou (Apex, Company Secretary)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZZGMMVFKGFZM
Date   Source Headline
1st Jun 20267:00 amRNSNet Asset Value(s)
1st Jun 20267:00 amRNSTotal Voting Rights
22nd May 20263:36 pmRNSResult of AGM
19th May 20267:00 amRNSNotice of AGM
1st May 20267:00 amRNSNet Asset Value(s)
1st May 20267:00 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSNotice of AGM and Rule 9 Waiver
29th Apr 20267:00 amRNSDividend Declaration
29th Apr 20267:00 amRNSAnnual Financial Report
29th Apr 20267:00 amRNSPublication of Annual Report
1st Apr 20267:00 amRNSNet Asset Value(s)
1st Apr 20267:00 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSNet Asset Value(s)
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Feb 20265:00 pmRNSHolding(s) in Company
2nd Feb 20267:00 amRNSNet Asset Value(s)
30th Jan 20265:00 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSNet Asset Value(s)
1st Dec 20257:00 amRNSNet Asset Value(s)
1st Dec 20257:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSNet Asset Value(s)
3rd Nov 20257:00 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSNet Asset Value(s)
1st Oct 20257:00 amRNSTotal Voting Rights
4th Sep 20257:00 amRNSHalf-year Report
1st Sep 20257:00 amRNSNet Asset Value(s)
1st Sep 20257:00 amRNSTotal Voting Rights
27th Aug 20257:00 amRNSDirectorate Change
1st Aug 20257:00 amRNSNet Asset Value(s)
1st Aug 20257:00 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSNet Asset Value(s)
1st Jul 20257:00 amRNSTotal Voting Rights
4th Jun 20254:24 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSNet Asset Value(s)
2nd Jun 20257:00 amRNSTotal Voting Rights
21st May 20254:32 pmRNSResult of AGM
6th May 20257:00 amRNSDirectorate Change
1st May 20257:00 amRNSNet Asset Value(s)
23rd Apr 20257:00 amRNSNotice of AGM and Rule 9 Waiver
23rd Apr 20257:00 amRNSDividend Declaration
23rd Apr 20257:00 amRNSAnnual Financial Report
23rd Apr 20257:00 amRNSPublication of Annual Report
1st Apr 20257:00 amRNSNet Asset Value(s)
3rd Mar 20257:00 amRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSNet Asset Value(s)
2nd Jan 20257:00 amRNSNet Asset Value(s)
2nd Dec 20247:00 amRNSNet Asset Value(s)
6th Nov 20246:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.